Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Publications: Haemophilus influenzae

2000 to Present:

 Top of Page  

1995-1999:

  • Centers for Disease Control and Prevention. Achievements in Public Health, 1900-1999 Impact of Vaccines Universally Recommended for Children - United States, 1990-1999. MMWR. 1999;48(12);243-8.
  • Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Haemophilus influenzae, 1999.
  • Jafari HS, Adams WG, Robinson KA, Plikaytis BD, Wenger JD. Efficacy of Haemophilus influenzae Type b conjugate vaccines and persistence of disease in disadvantaged populations. The Haemophilus Influenzae Study Group. Am J Public Health 1999;89:364-8.
  • Bisgard K, Kao A, Leake J, Strebel PM, Perkins BA, Wharton M. Haemophilus influenzae disease in the United States, 1994-1995: Near disappearance of a vaccine-preventable childhood disease. Emerg Infect Dis. 1998;4:229-37.
  • Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Haemophilus influenzae, 1998.
  • Centers for Disease Control and Prevention. Progress Toward Elimination of Haemophilus influenzae Type b Disease Among Infants and Children -- United States, 1987-1997. MMWR. 1998;47:993-8.
  • Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Haemophilus influenzae, 1997.
  • Centers for Disease Control and Prevention. Progress Toward Elimination of Haemophilus influenzae type b disease among infants and children -- United States, 1987-1995. MMWR. 1996;45(42):901-6.
  • Urwin G, Krohn JA, Deaver-Robinson K, Wenger JD, Farley MM, and the H. Influenzae study group. Invasive Haemophilus influenzae serotype f disease: Clinical and epidemiological characteristics in the Hib vaccine era. Clin Inf Dis. 1996;22:1069-76.
  • Centers for Disease Control and Prevention. Progress toward elimination of Haemophilus influenzae Type b disease among infants and children-United States, 1993-1994. MMWR. 1995;44(29):545-50.

 Top of Page  

1988 - 1994:

  • Centers for Disease Control and Prevention. Progress Toward elimination of Haemophilus influenzae type b disease among infants and children--United States, 1987-1993. MMWR. 1994;43(8):144-8.
  • Adams WG, Deaver KA, Cochi SL, Plikaytis BD, Zell ER, Broome CV, et al. Decline of childhood Haemophilus influenzae Type b (Hib) disease in the Hib vaccine era. JAMA. 1993;269:221-6.
  • Farley MM, Stephens DS, Brachman PS Jr, Harvey RC, Smith JD, Wenger JD. Invasive Haemophilus influenzae Disease in Adults: Population-Based Surveillance. Ann Intern Med. 1992;116:806-12.
  • Farley MM, Stephens DS, Harvey RC, Sikes RK, Wenger JD, and the CDC Meningitis Surveillance Group. Incidence and Clinical Characteristics of Invasive Haemophilus influenzae in Adults. J Infect Dis. 1992;165:S42-3.
  • Wenger JD, Pierce R, Deaver K, Franklin R, Bosley G, Pigott N, et al. Invasive Haemophilus influenzae disease: A population-based evaluation of the role of capsular polysaccharide serotype. J Infect Dis. 1992;165 [Suppl. 1]:S34-5.
  • Wenger JD, Pierce R, Deaver KA, Plikaytis BD, Facklam RR, Broome CV, and the Haemophilus influenzae Vaccine Efficacy Study Group. Efficacy of Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine in US children aged 18-59 months. Lancet. 1991;338:395-8.
  • Wenger JD, Harrison LH, Hightower A, Broome CV. Day care characteristics associated with Haemophilus influenzae disease. Am J Public Health. 1990;80:1455-8.
  • Harrison LH, Broome CV, Hightower AW. Haemophilus influenzae type b polysaccharide vaccine: an efficacy study. Pediatrics. 1989;84:255-61.
  • Harrison LH, Broome CV, Hightower AW, Hoppe CC, Makintubee S, Sitze SL, et al. A day care-based study of the efficacy of Haemophilus b polysaccharide vaccine. JAMA. 1988;260:1413-8.
 Top of Page
Top